Search - tctmd.com

Displaying 1 - 20 of 43

Sort: Relevancy | Date

Presentation TCT 2025

Trans-Femoral Intramyocardial Septal Radiofrequency Ablation (tf-PIMSRA) in Patients with Symptomatic HOCM: Technology Demonstration and Results of the PRIMO Study

Presenter: Yiyuan Huang

October 28, 2025

Presentation TCT 2025

Transcatheter Radiofrequency-Based Mitral Annuloplasty (BioRefine)

Presenter: Jozef Bartunek

October 28, 2025

Presentation TCT 2025

First Report of the SPYRAL AFFIRM Study: Reduced Home and Office Blood Pressure Following Radiofrequency Renal Denervation in a Large US Cohort of High Cardiovascular Risk Patients.

Presenter: Felix Mahfoud

October 27, 2025

Presentation TCT 2025

TCT 44: Procedural Outcomes of Pulsed Field Versus Radiofrequency Ablation in Persistent Atrial Fibrillation

Presenter: Mounica Vorla

October 27, 2025

Presentation TCT 2025

TCT 582: Ultrasound vs. Radiofrequency Renal Denervation: A Comparative Analysis

Presenter: Anmol Multani

October 27, 2025

Presentation TCT 2025

ARS 3: Radiofrequency Ablation and the Treatment of Chronic Medical Conditions

Presenter: Joe Mullings

October 25, 2025

Presentation THT 2025

Reduced Heart Failure Rehospitalization at 1 Year for Patients Managed Using a Radiofrequency-Based Sensor

Presenter: John Boehmer

February 12, 2025

Presentation TCT 2024

Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN

Presenter: Lucas Lauder

October 28, 2024

Presentation TCT 2024

TCT 481: Renal Artery Imaging Through Long-Term Follow-Up Following Radiofrequency Renal Denervation: Results From the SPYRAL Clinical Trial Program

Presenter: Felix Mahfoud

October 28, 2024

Presentation TCT 2024

TCT 480: Blood Pressure Reductions by Radiofrequency Renal Denervation Procedural Characteristics: Pooled 24-Month Results From the SYMPLICITY Clinical Program

Presenter: Felix Mahfoud

October 28, 2024

Presentation TCT 2024

Radiofrequency, Ultrasound, or Alcohol- How Different Are The Devices and What Do I Need To Consider?

Presenter: Tai Kobayashi

October 28, 2024

Presentation TCT 2024

TCT 540: Second-Generation Cryoballoon Ablation vs Contact-Force Sensing Radiofrequency Ablation in Paroxysmal Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis

Presenter: Abdul Wali Khan

October 28, 2024

Presentation TCT 2024

Long-term Safety and Efficacy of Radiofrequency Renal Denervation in the Presence of Antihypertensive Drugs: 24-Month Results From the SPYRAL HTN-ON MED Randomized Trial

Presenter: David Kandzari

October 28, 2024

Presentation TCT 2023

TCT 267: Pooled, 12-month Blood Pressure Reductions Using the Symplicity Spyral Radiofrequency Renal Denervation Catheter

Presenter: Felix Mahfoud

October 25, 2023

Presentation TVT 2023

Leaflet laceration using "Percutaneous balloon valvotomy": Utilizing UNICORN (Undermining Coronary Obstruction with Radiofrequency Needle ablation) for TAVR in TAVR.

Presenter: Megan Toole

June 10, 2023

Presentation EuroPCR 2023

Effectiveness and Safety of the NetrodTM Six-Electrode Radiofrequency Renal Denervation System for the Treatment of Uncontrolled Essential Hypertension

Presenter: Yu-Jie Zhou

May 17, 2023

Presentation TCT 2022

TCT 665: Endocardial radiofrequency septal ablation before TAVI: A novel approach to prevent suicide ventricle

Presenter: Bruno Valdigem

September 19, 2022

Presentation TCT 2022

Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation)

Presenter: David Kandzari

September 17, 2022

Presentation TVT 2022

Percutaneous Intramyocardial Septal Radiofrequency Ablation (PIMSRA) for Hypertrophic Obstructive Cardiomyopathy: Results From the First 200 Patients

Presenter: David Hsi

June 09, 2022

Presentation TCT 2021

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Presenter: David E. Kandzari

November 04, 2021

Advertisement

Trans-Femoral Intramyocardial Septal Radiofrequency Ablation (tf-PIMSRA) in Patients with Symptomatic HOCM: Technology Demonstration and Results of the PRIMO Study

Transcatheter Radiofrequency-Based Mitral Annuloplasty (BioRefine)

First Report of the SPYRAL AFFIRM Study: Reduced Home and Office Blood Pressure Following Radiofrequency Renal Denervation in a Large US Cohort of High Cardiovascular Risk Patients.

TCT 44: Procedural Outcomes of Pulsed Field Versus Radiofrequency Ablation in Persistent Atrial Fibrillation

TCT 582: Ultrasound vs. Radiofrequency Renal Denervation: A Comparative Analysis

ARS 3: Radiofrequency Ablation and the Treatment of Chronic Medical Conditions

Reduced Heart Failure Rehospitalization at 1 Year for Patients Managed Using a Radiofrequency-Based Sensor

Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN

TCT 481: Renal Artery Imaging Through Long-Term Follow-Up Following Radiofrequency Renal Denervation: Results From the SPYRAL Clinical Trial Program

TCT 480: Blood Pressure Reductions by Radiofrequency Renal Denervation Procedural Characteristics: Pooled 24-Month Results From the SYMPLICITY Clinical Program

Radiofrequency, Ultrasound, or Alcohol- How Different Are The Devices and What Do I Need To Consider?

TCT 540: Second-Generation Cryoballoon Ablation vs Contact-Force Sensing Radiofrequency Ablation in Paroxysmal Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis

Long-term Safety and Efficacy of Radiofrequency Renal Denervation in the Presence of Antihypertensive Drugs: 24-Month Results From the SPYRAL HTN-ON MED Randomized Trial

TCT 267: Pooled, 12-month Blood Pressure Reductions Using the Symplicity Spyral Radiofrequency Renal Denervation Catheter

Leaflet laceration using "Percutaneous balloon valvotomy": Utilizing UNICORN (Undermining Coronary Obstruction with Radiofrequency Needle ablation) for TAVR in TAVR.

Effectiveness and Safety of the NetrodTM Six-Electrode Radiofrequency Renal Denervation System for the Treatment of Uncontrolled Essential Hypertension

TCT 665: Endocardial radiofrequency septal ablation before TAVI: A novel approach to prevent suicide ventricle

Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation)

Percutaneous Intramyocardial Septal Radiofrequency Ablation (PIMSRA) for Hypertrophic Obstructive Cardiomyopathy: Results From the First 200 Patients

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content